STOCK TITAN

Brandywine Realty Trust Announces Full Lease-Up at 250 Radnor with 119,000-Square-Foot Lease to Global Industrial Leader

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Brandywine Realty Trust (NYSE: BDN) has announced a 119,000-square-foot lease with a global industrial solutions leader at 250 Radnor, achieving 100% occupancy. The 168,000-square-foot building, converted from a medical office to a state-of-the-art lab facility, hosts tenants including West Pharmaceutical, Quanta Therapeutics, and Penn Medicine. Located within the 26.6-acre Radnor Life Science Center, the property features extensive amenities and is part of a mixed-use, transit-oriented campus. The campus also includes 155 Radnor, a 145,000-square-foot office building fully leased to Arkema S.A., set to welcome employees this fall.

Brandywine Realty Trust (NYSE: BDN) ha annunciato un contratto di locazione di 119.000 piedi quadrati con un leader globale nelle soluzioni industriali presso 250 Radnor, raggiungendo così il 100% di occupazione. L'edificio di 168.000 piedi quadrati, trasformato da ufficio medico a una struttura laboratoriale all'avanguardia, ospita inquilini tra cui West Pharmaceutical, Quanta Therapeutics e Penn Medicine. Situato all'interno del Radnor Life Science Center di 26,6 acri, la proprietà offre un'ampia gamma di servizi ed è parte di un campus misto orientato al trasporto. Il campus include anche 155 Radnor, un edificio per uffici di 145.000 piedi quadrati totalmente affittato a Arkema S.A., che accoglierà i dipendenti questo autunno.

Brandywine Realty Trust (NYSE: BDN) ha anunciado un contrato de arrendamiento de 119,000 pies cuadrados con un líder global en soluciones industriales en 250 Radnor, alcanzando así una ocupación del 100%. El edificio de 168,000 pies cuadrados, convertido de oficina médica a instalación de laboratorio de última generación, alberga inquilinos como West Pharmaceutical, Quanta Therapeutics y Penn Medicine. Ubicado dentro del Radnor Life Science Center de 26.6 acres, la propiedad cuenta con amplias comodidades y es parte de un campus mixto orientado al transporte. El campus también incluye 155 Radnor, un edificio de oficinas de 145,000 pies cuadrados completamente alquilado a Arkema S.A., que recibirá a los empleados este otoño.

브랜디와인 리얼티 트러스트 (NYSE: BDN)는 250 라드너에서 글로벌 산업 솔루션 리더와 11만9천 평방피트 임대 계약을 체결하여 100% 점유율을 달성했습니다. 16만8천 평방피트 건물은 의료 사무실에서 최첨단 연구소 시설로 변환되었으며, 웨스트 제약, 푼타 테라퓨틱스, 펜 메디신과 같은 세입자가 있습니다. 26.6에이커 규모의 라드너 생명과학 센터 내에 위치한 이 시설은 다양한 편의 시설을 갖추고 있으며, 교통 중심의 복합 용도 캠퍼스의 일부입니다. 이 캠퍼스에는 Arkema S.A.에 완전히 임대된 14만5천 평방피트 규모의 사무실 건물 155 라드너가 포함되어 있으며, 이 가을 직원들이 입주할 예정입니다.

Brandywine Realty Trust (NYSE: BDN) a annoncé un bail de 119 000 pieds carrés avec un leader mondial en solutions industrielles au 250 Radnor, atteignant ainsi une occupation de 100 %. Le bâtiment de 168 000 pieds carrés, converti d'un bureau médical en un laboratoire à la pointe de la technologie, accueille des locataires tels que West Pharmaceutical, Quanta Therapeutics et Penn Medicine. Situé dans le Radnor Life Science Center de 26,6 acres, la propriété bénéficie d'un large éventail de commodités et fait partie d'un campus polyvalent axé sur le transport. Le campus comprend également le 155 Radnor, un bâtiment de bureaux de 145 000 pieds carrés entièrement loué à Arkema S.A., qui accueillera ses employés cet automne.

Brandywine Realty Trust (NYSE: BDN) hat einen Vertrag über 119.000 Quadratfuß mit einem globalen Branchenführer im Bereich industrielle Lösungen in 250 Radnor bekannt gegeben und erreicht damit eine 100%ige Belegung. Das 168.000 Quadratfuß große Gebäude, das von einem medizinischen Büro in eine hochmoderne Laborfläche umgewandelt wurde, beherbergt Mieter wie West Pharmaceutical, Quanta Therapeutics und Penn Medicine. Die Immobilie befindet sich innerhalb des Radnor Life Science Centers auf 26,6 Acres und bietet umfangreiche Annehmlichkeiten und ist Teil eines gemischten, transportorientierten Campus. Der Campus umfasst auch 155 Radnor, ein 145.000 Quadratfuß großes Bürogebäude, das vollständig an Arkema S.A. vermietet ist und diesen Herbst die Mitarbeiter willkommen heißen wird.

Positive
  • Achieved 100% occupancy at 250 Radnor with new 119,000-square-foot lease
  • Successfully converted medical office building into high-demand lab space
  • Secured high-profile tenants including West Pharmaceutical, Quanta Therapeutics, and Penn Medicine
  • 155 Radnor building fully leased to Arkema S.A.
Negative
  • None.

Insights

The full lease-up of 250 Radnor represents a significant achievement for Brandywine Realty Trust, demonstrating strong demand for life science and office space in their portfolio. The 119,000-square-foot lease brings the 168,000-square-foot building to 100% occupancy, strengthening the REIT's revenue stability. The tenant mix, including West Pharmaceutical, Quanta Therapeutics and Penn Medicine, validates the property's positioning in the life science sector.

The successful transformation from medical office to lab space showcases BDN's ability to execute value-add renovations and capitalize on the growing life science market. The Radnor Life Science Center's full occupancy, including Arkema's headquarters at 155 Radnor, indicates strong market fundamentals in the Philadelphia suburb and supports potential rental rate growth. This lease-up enhances the property's income security and could positively impact the REIT's overall portfolio performance.

PHILADELPHIA, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Brandywine Realty Trust (NYSE: BDN) today announced the execution of a 119,000-square-foot lease with a global leader in industrial solutions at 250 Radnor, bringing the building to 100% leased. This milestone reinforces 250 Radnor's position as a premier life science and office destination within one of the most dynamic submarkets in the country.

250 Radnor, a 168,000-square-foot adaptive reuse project, transformed an existing medical office building into a state-of-the-art facility designed to fully accommodate lab tenants. Current tenants include West Pharmaceutical, Quanta Therapeutics, and Penn Medicine, reflecting the growing demand for cutting-edge lab and research space in Radnor.

Situated within the Radnor Life Science Center, a 26.6-acre mixed-use, transit-oriented campus, 250 Radnor exemplifies Brandywine Realty Trust's commitment to sustainable and innovative development. The Radnor Life Science Center features world-class amenities, including gardens, trails, 250 newly planted trees, wildflower meadows, two courtyards, and a pavilion, seamlessly integrated into the natural environment. Additionally, the campus is home to Penn Medicine's state-of-the-art medical facility and 155 Radnor, which serves as Arkema's North American headquarters.

Recent updates to the campus include the completion of the 145,000-square-foot office building at 155 Radnor, which is fully leased to Arkema S.A., a global supplier of specialty materials. The building is set to welcome employees this fall, marking another significant step forward in the development of Radnor Life Science Center.

"As we continue to establish Radnor Life Science Center as a vibrant hub for innovation, the full lease-up of 250 Radnor represents a major achievement in our development leasing," said Jeff DeVuono, Executive Vice President, Life Sciences, at Brandywine Realty Trust. "We are proud to deliver top-tier lab pace in a thoughtfully designed, sustainable environment that supports our tenants' missions and further demonstrates our progress in diversifying our revenue through the establishment of innovation hubs across our platform."

To learn more about Radnor Life Science Center and Brandywine Realty Trust, visit www.brandywinerealty.com.

About Brandywine Realty Trust

Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 147 properties and 21.1 million square feet as of September 30, 2024. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together. For more information, please visit www.brandywinerealty.com.

Company / Investor Contact:
Tom Wirth
EVP & CFO
610-832-7434
tom.wirth@bdnreit.com


FAQ

What is the size of the new lease at Brandywine's 250 Radnor building (BDN)?

The new lease at 250 Radnor is 119,000 square feet, bringing the building to 100% occupancy.

Who are the current tenants at Brandywine's 250 Radnor building (BDN)?

Current tenants at 250 Radnor include West Pharmaceutical, Quanta Therapeutics, Penn Medicine, and a global leader in industrial solutions.

What is the total size of Brandywine's Radnor Life Science Center campus (BDN)?

The Radnor Life Science Center is a 26.6-acre mixed-use, transit-oriented campus.

When will Arkema employees move into 155 Radnor at Brandywine's campus (BDN)?

Arkema employees are set to move into the 155 Radnor building in fall 2024.

Brandywine Realty Trust

NYSE:BDN

BDN Rankings

BDN Latest News

BDN Stock Data

899.82M
172.67M
2.56%
89.02%
6.35%
REIT - Office
Real Estate Investment Trusts
Link
United States of America
PHILADELPHIA